Swedish Exhibition and Conference Centre
Göteborg, Sweden

Estoril Congress Centre, Lisbon

Paris, France
CNIT Paris La Defense

Hill St, Birmingham B5 4EW

Our clinical team is thrilled to share that we will be participating in the BSA Scientific Meeting, a prominent UK scientific forum uniting clinicians and researchers interested in hearing, tinnitus, and balance. We are excited to showcase our advancements in clinical development for advanced therapeutics addressing neural hearing loss. Additionally, we will have a booth where you can meet our team and learn more about our pioneering approaches to treating hearing loss. We look forward to engaging with you at the event!

Radisson Collection Hotel, Grand Place Brussels, Rue du Fossé aux Loups, Brussels, Belgium

Our CEO, Simon Chandler, and CTO, Terri Gaskell, will participate at the Economist Impact’s Cell and Gene Therapy 2024. This prestigious event gathers global industry leaders and healthcare stakeholders to explore the future of these breakthrough therapies. They’ll engage in vital discussions on overcoming the barriers to advancing cell and gene therapies and enhancing patient access. With innovative treatments emerging rapidly, these therapies are poised to transform healthcare and offer new hope to patients previously without options. The conference will address the critical challenges of integrating advanced therapies into mainstream healthcare. Topics include regulatory changes, evolving delivery models, clinical trial structuring, and the use of real-world evidence to not only improve patient outcomes but also to sustain competitive advantage for companies. Stay tuned for updates as we aim to shape a healthier future together!

St Mary’s Square, Gateshead NE8 2JR

Our executive and clinical teams are excited to announce our participation in the 2024 BCIG Annual Conference, where we will be engaging with hearing loss professionals specialising in Cochlear implantation. Our VP of Clinical Development and Operations, Rachel Haines, alongside our CTO Terri Gaskell, will be presenting our journey from the preclinical development of our groundbreaking cell therapy, Rincell-1, to our forthcoming first human clinical trial. Dr. Tia Papoutselou, one of our clinical development scientists, will also be sharing our research on clinical pathways for patients with ANSD in the UK. Additionally, we will have an exhibitor’s stand. We invite you to join us for discussions on our innovative approaches to treating hearing loss.